Top Markets
#1 ADO Protocol ADO Protocol +334.60%
#2 Islamic Coin Islamic Coin +155.41%
#3 GoPlus Security GoPlus Security +38.11%
#4 Starpower Starpower +37.90%
#5 GAIB AID GAIB AID +24.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.81%
#7 Casper Network Casper Network +14.74%
#8 Power Protocol Power Protocol +11.88%
#9 Ontology Gas Ontology Gas +11.67%
#10 Nockchain Nockchain +11.57%
Coin of the day
ADO Protocol ADO Protocol
Setări
Limbă
ROMâNă
Monedă
USD
Temă
NightHawk Biosciences, Inc. NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc.

NHWK
Rang în acțiuni #33280
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm,... NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.
Preț acțiune
$0.3136
Ultima sincronizare: 2024-03-04
Capitalizare de piață
$7.97M
Schimbare (1 zi)
-3.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează NightHawk Biosciences, Inc. (NHWK)

Categorie

Healthcare
Istoric al prețului acțiunii pentru NightHawk Biosciences, Inc. (NHWK)
Cel mai mare preț de închidere: $0.32 pe 2024-03-01

Cel mai mic preț de închidere: $1.61K pe 2006-02-01
Istoric al prețului acțiunii pentru NightHawk Biosciences, Inc. din 2006 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2024 -12.72%
2023 -62.73%
2022 -74.60%
2021 -38.90%
2020 94.88%
2019 -61.16%
2018 -69.55%
2017 -57.98%
2016 -61.68%
2015 -42.63%
2014 -45.31%
2013 19.58%
2010 39.45%
2009 26.00%
2008 -82.79%
2007 -12.37%
2006 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 7.08%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.26 13.28%
BE